A dose response study of oxitropium bromide in chronic bronchitis.
Open Access
- 1 June 1984
- Vol. 39 (6) , 453-456
- https://doi.org/10.1136/thx.39.6.453
Abstract
In a dose response study 12 patients with chronic bronchitis and airflow obstruction received inhaled placebo and incremental doses of oxitropium bromide. Significant improvements in peak expiratory flow rate, forced expiratory volume in one second, and forced vital capacity were recorded at all times up to 10 hours after all doses of oxitropium bromide. Oxitropium bromide is an effective bronchodilator in chronic bronchitis with an optimal dose of 400-600 micrograms.Keywords
This publication has 3 references indexed in Scilit:
- Peak Expiratory Flow in Normal SubjectsBMJ, 1973
- Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis.1965
- Multiple Range and Multiple F TestsPublished by JSTOR ,1955